XML 20 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings (Loss) Per Share
9 Months Ended
Oct. 29, 2021
Earnings Per Share Basic And Diluted [Abstract]  
Earnings (Loss) Per Share

NOTE 3. EARNINGS (LOSS) PER SHARE

 

The numerator for both basic and diluted EPS is net income (loss). The denominator for basic EPS is based upon the number of weighted average shares of Lands’ End common stock outstanding during the reporting periods. The denominator for diluted EPS is based upon the number of weighted average shares of Lands’ End common stock and common stock equivalents outstanding during the reporting periods using the treasury stock method in accordance with GAAP. Potentially dilutive securities for the diluted EPS calculations consist of non-vested equity shares of common stock and in-the-money outstanding options where the current stock price exceeds the option strike price.

 

The following table summarizes the components of basic and diluted EPS:

 

 

 

13 Weeks Ended

 

 

39 Weeks Ended

 

(in thousands, except per share amounts)

 

October 29, 2021

 

 

October 30, 2020

 

 

October 29, 2021

 

 

October 30, 2020

 

Net income (loss)

 

$

7,399

 

 

$

7,176

 

 

$

26,259

 

 

$

(9,091

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average common shares outstanding

 

 

32,981

 

 

 

32,605

 

 

 

32,910

 

 

 

32,551

 

Dilutive effect of stock awards

 

 

717

 

 

 

643

 

 

 

798

 

 

 

 

Diluted weighted average common shares outstanding

 

 

33,698

 

 

 

33,248

 

 

 

33,708

 

 

 

32,551

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings (loss) per share

 

$

0.22

 

 

$

0.22

 

 

$

0.80

 

 

$

(0.28

)

Diluted earnings (loss) per share

 

$

0.22

 

 

$

0.22

 

 

$

0.78

 

 

$

(0.28

)

 

Stock awards are considered anti-dilutive based on the application of the treasury stock method or in the event of a net loss. Anti-dilutive shares excluded from the diluted weighted average shares outstanding were 142 anti-dilutive shares in the 13 weeks ended October 29, 2021, 570,364 anti-dilutive shares in the 13 weeks ended October 30, 2020, 77 anti-dilutive shares in the 39 weeks ended October 29, 2021 and 1,213,317 anti-dilutive shares in the 39 weeks ended October 30, 2020.